Literature DB >> 24991776

A comprehensive profile of the sociodemographic, psychosocial and health characteristics of Ontario home care clients with dementia.

M Vu1, D B Hogan2, S B Patten3, N Jetté4, S E Bronskill5, G Heckman6, M J Kergoat7, J P Hirdes6, X Chen6, M M Zehr8, C J Maxwell9.   

Abstract

INTRODUCTION: This study provides a comprehensive summary of the sociodemographic, psychosocial and health characteristics of a large population-based cohort of Ontario home care clients (aged 50 years and over) with dementia and examines the variation in these characteristics in those with co-existing neurological conditions.
METHODS: Clients were assessed with the Resident Assessment Instrument-Home Care (RAI-HC) between January 2003 and December 2010. Descriptive analyses examined the distribution of these characteristics among clients with dementia relative to several comparison groups, as well as clients with other recorded neurological conditions.
RESULTS: Approximately 22% of clients (n=104 802) had a diagnosis of dementia (average age 83 years, 64% female) and about one in four within this group had a co-existing neurological condition (most commonly stroke or Parkinson disease). About 43% of those with dementia did not live with their primary caregiver. Relative to several comparison groups, clients with dementia showed considerably higher levels of cognitive and functional impairment, aggression, anxiety, wandering, hallucinations/delusions, caregiver distress and a greater risk for institutionalization. Conversely, they showed a lower prevalence of several chronic conditions and lower levels of recent health service use. Depressive symptoms were relatively common in the dementia and other neurological groups.
CONCLUSION: Clients with co-existing neurological conditions exhibited unique clinical profiles illustrating the need for tailored and flexible home care services and enhanced caregiver assistance programs.

Entities:  

Keywords:  Alzheimer disease; dementia; home care; mental health; neurological disorders

Mesh:

Year:  2014        PMID: 24991776

Source DB:  PubMed          Journal:  Chronic Dis Inj Can        ISSN: 1925-6515


  6 in total

1.  Patterns and determinants of dementia pharmacotherapy in a population-based cohort of home care clients.

Authors:  Colleen J Maxwell; Mary Vu; David B Hogan; Scott B Patten; Micaela Jantzi; Marie-Jeanne Kergoat; Nathalie Jetté; Susan E Bronskill; George Heckman; John P Hirdes
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

2.  Multimorbidity and healthcare utilization among home care clients with dementia in Ontario, Canada: A retrospective analysis of a population-based cohort.

Authors:  Luke Mondor; Colleen J Maxwell; David B Hogan; Susan E Bronskill; Andrea Gruneir; Natasha E Lane; Walter P Wodchis
Journal:  PLoS Med       Date:  2017-03-07       Impact factor: 11.069

3.  A longitudinal study looking at and beyond care recipient health as a predictor of long term care home admission.

Authors:  Raquel S D Betini; John P Hirdes; Donna S Lero; Susan Cadell; Jeff Poss; George Heckman
Journal:  BMC Health Serv Res       Date:  2017-11-09       Impact factor: 2.655

4.  Associations with rates of falls among home care clients in Ontario, Canada: a population-based, cross-sectional study.

Authors:  Derek R Manis; Caitlin McArthur; Andrew P Costa
Journal:  BMC Geriatr       Date:  2020-02-27       Impact factor: 3.921

5.  Towards defining quality in home care for persons living with dementia.

Authors:  Marianne Saragosa; Lianne Jeffs; Karen Okrainec; Kerry Kuluski
Journal:  PLoS One       Date:  2022-09-13       Impact factor: 3.752

6.  Variation in the health outcomes associated with frailty among home care clients: relevance of caregiver distress and client sex.

Authors:  Colleen J Maxwell; Michael A Campitelli; Christina Diong; Luke Mondor; David B Hogan; Joseph E Amuah; Sarah Leslie; Dallas Seitz; Sudeep Gill; Kednapa Thavorn; Walter P Wodchis; Andrea Gruneir; Gary Teare; Susan E Bronskill
Journal:  BMC Geriatr       Date:  2018-09-12       Impact factor: 3.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.